About CustomArray
CustomArray is a Healthcare company based in Redmond (United States) founded in 2010, and was acquired by GenScript in December 2017. Array-synthesized DNA capture probes are developed for targeted NGS sequencing. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include Neogen, RareCyte and Paragon Genomics; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2010 and based in Redmond, United States, CustomArray operates in the biotechnology sector. Microarrays are developed by the company, allowing probe designs and arrays to be updated as new sequences become available. An ElectraSense platform is offered, utilizing electrochemical reactions for probe measurement in reduced time. Oligo pools are provided as collections of oligonucleotides for user-defined sequences in gene mutation screening, protein optimization, and drug discovery applications.
- Headquarters Redmond, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website customarrayinc.com
- Social LinkedIn
- Acquired by GenScript (Dec 2017)
Investors in CustomArray
CustomArray has secured backing from 1 investor. Prominent investors backing the company include GenScript.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Reagents and instruments are provided for life sciences research. | 2002 | genscript.com | Piscataway, United States |
Investor details for CustomArray
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CustomArray
2 dated milestones of CustomArray across 7 years, from founding to its latest funding, stage changes and deals.
- Founded CustomArray is founded.
- Exit Acquired by GenScript.
Competitors of CustomArray
CustomArray has 3 listed competitors in our database, 3 of them funded. They include Neogen, RareCyte and Paragon Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| paragongenomics.com | 2015 | San Francisco, United States | $8M | 26 | Provider of technologies and solutions genomic research and precision medicine |
Detailed competitors of CustomArray
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CustomArray
Websites that share an audience with CustomArray (customarrayinc.com).
Websites whose visitors overlap most with CustomArray. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cd-genomics.com | cd-genomics.com | 100% | #300,823 | – | |
| affymetrix.com | 85% | 1.1K | #9,164,392 | View details | |
| genelink.com | 74% | 10.8K | #2,265,843 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as CustomArray (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Customarray
Complete news archive for CustomArray
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CustomArray
CustomArray was founded in 2010.
CustomArray is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
Founded in 2010 and based in Redmond, United States, CustomArray operates in the biotechnology sector. Microarrays are developed by the company, allowing probe designs and arrays to be updated as new sequences become available. An ElectraSense platform is offered, utilizing electrochemical reactions for probe measurement in reduced time. Oligo pools are provided as collections of oligonucleotides for user-defined sequences in gene mutation screening, protein optimization, and drug discovery applications.
CustomArray's top competitors include Neogen, Paragon Genomics and RareCyte.
CustomArray has 1 investor. Key investors include GenScript.
Yes. CustomArray was acquired by GenScript in December 2017.